Select publications

Kembuan, G. J.*, Kim, J. Y.*, Maus, M. V., & Jan, M. (2024). Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology. Trens in Cancer, https://doi.org/10.1016/j.trecan.2024.01.003.

Kann, M. C., Schneider, E. M., Almazan, A. J., Lane, I. C., Bouffard, A. A., Supper, V. M., Takei, H. N., Tepper, A., Leick, M. B., Larson, R. C., Ebert, B. L., Maus, M. V., & Jan, M. (2023). Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7. Leukemia, 1-11.

Lane, I. C., Kembuan, G., Carreiro, J., Kann, M. C., Lin, W., Bouffard, A. A., Kreuzer, J., Morris, R., Schneider E. M., Kim, J. Y., Zou, C., Salas-Benito, D., Gasser, J. A., Leick, M. B., Slabicki, M., Haas, W., Maus, M. V., & Jan, M. (2023). Genetic retargeting of E3 ligases to enhance CAR T cell therapy. Cell Chemical Biology, Nov 14:S2451-9456(23)00386-0.

Lane, I. C. & Jan, M. (2022). SEAKER cells coordinate cellular immunotherapy with localized chemotherapy. Trends in Pharmacological Sciences.

Jan, M.*, Sperling, A. S.*, & Ebert, B. L. (2021). Cancer therapies based on targeted protein degradation—lessons learned with lenalidomide. Nature Reviews Clinical Oncology, 1-17. *equal contribution.

Jan, M., Scarfò, I., Larson, R. C., Walker, A., Schmidts, A., Guirguis, A. A., ... Maus, M. V., & Ebert, B. L. (2021). Reversible ON-and OFF-switch chimeric antigen receptors controlled by lenalidomide. Science translational medicine, 13(575).

Jan, M., Leventhal, M. J., Morgan, E. A., Wengrod, J. C., Nag, A., Drinan, S. D., ... & Ebert, B. L. (2019). Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation. Blood advances, 3(14), 2199-2204.

Jan, M.*, Snyder, T. M.*, Corces-Zimmerman, M. R.*, Vyas, P., Weissman, I. L., Quake, S. R., & Majeti, R. (2012). Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Science translational medicine, 4(149), 149ra118-149ra118. *equal contribution.

All publications via google scholar.